Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPability-01: Sintilimab and Chidamide +/- Bevacizumab in pMMR/MSS Colorectal Cancer
NCT04724239Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Mar 2021
- Primary completion
- Jul 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in colorectal adenocarcinoma, sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
colorectal adenocarcinoma
Beyond the preview
Go deeper on NCT04724239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04724239.